Form 4 Filing for Cellectar Biosciences, Inc. - Swirsky Douglas J

This filing details a Form 4 submission for Cellectar Biosciences, Inc. (CLRB), concerning transactions by reporting owner Douglas J. Swirsky. On July 7, 2026, Swirsky was granted an option to acquire 37,500 shares of common stock at an exercise price of $2.70 per share. This option vests fully on July 7, 2027, contingent upon Swirsky's continued service. The option has an expiration date of July 7, 2036. The transaction is marked as direct ownership. The filing was signed by Chad Kolean, attorney-in-fact for Douglas Swirsky, on July 8, 2026.